Company profile
RavenQuest BioMed Inc.
OTC: RVVQF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Vancouver, BCReports USD
#878 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ —GM —SS 23
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), balance-sheet leverage · ↓ Piotroski F, market scale
Methodology →Revenue TTM
$1.1M
Rev growth YoY (TTM)
-3.8%
Net income (FY)
-$23.7M
Employees
—
as of 2026-07-12
Market cap
$1.2k
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$976.6k1.3M CAD2018
Net income-$23.7M-30.5M CAD2018
Operating income-$13.3M-17.2M CAD2018
Total assets$28.7M37.7M CAD2018
Liabilities$11.7M15.3M CAD2018
Equity$17.0M22.4M CAD2018
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is RavenQuest BioMed Inc.’s revenue?
RavenQuest BioMed Inc. booked $976.6k in FY2018 revenue, growing 1032% year over year — faster than 96% of Healthcare companies we track, at a -2423.9% net margin.
Peers · Healthcare
Ehouse Global, Inc.——60 Degrees Pharmaceuticals, Inc.34DShattuck Labs, Inc.49DThe CannaBusiness Group, Inc.——INDVR Brands Inc.——Quick-Med Technologies, Inc.——Key facts
CEODavid Allen Cross
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVancouver, BC
ExchangeOTC: RVVQF
Employees—
IPO date2018-03-05
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.